Also known as: Pirarubicin HCl; THP-Adriamycin Hydrochloride
Pirarubicin Hydrochloride is the hydrochloride salt form of pirarubicin, an anthracycline antineoplastic agent. As the hydrochloride salt, it offers improved water solubility and formulation stability. It is used in oncology for the treatment of various cancers including breast cancer and bladder tumors. Mediocon Inc manufactures Pirarubicin Hydrochloride API at its GMP-certified facility in Aurangabad, Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 155596-90-0 |
| Molecular Formula | C32H35NO12 · HCl |
| Molecular Weight | 664.08 g/mol |
| Grade | IP / BP / USP |
| Category | Antineoplastic Agent (Anthracycline) |
| Appearance | Red to reddish-purple crystalline powder |
| Solubility | Freely soluble in water, sparingly soluble in ethanol, practically insoluble in ether |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PIRH/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |